CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma

Kiyohiro Ando(Nihon University), Satoshi Wada(Showa University)
Journal of Oncology
September 15, 2020
Cited by 7


Related Papers